MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Lantheus Holdings, Inc. - Common Stock (NQ:LNTH)

83.94 +1.20 (+1.45%)
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 15, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 753,404
Open 83.23
Bid (Size) 80.00 (100)
Ask (Size) 84.00 (100)
Prev. Close 82.74
Today's Range 82.37 - 83.97
52wk Range 47.25 - 108.91
Shares Outstanding 67,604,097
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
3 Profitable Stocks We Think Twice About
Even if a company is profitable, it doesn’t always mean it’s a great investment. Some struggle to maintain growth, face looming threats, or fail to reinvest ... 
Via StockStory
News headline image
3 Cash-Producing Stocks Walking a Fine Line
Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it eff... 
Via StockStory

Performance

YTD
+24.8%
+24.8%
1 Month
+6.9%
+6.9%
3 Month
+28.0%
+28.0%
6 Month
+48.5%
+48.5%
1 Year
-18.3%
-18.3%

More News

Read More
News headline image
1 of Wall Street’s Favorite Stock for Long-Term Investors and 2 We Ignore
Via StockStory
News headline image
3 Russell 2000 Stocks We’re Skeptical Of
Via StockStory
Lantheus Holdings Inc (NASDAQ:LNTH) Beats Q4 Estimates but 2026 Guidance Disappoints ↗
Via Chartmill
Lantheus Holdings Inc. (NASDAQ:LNTH) Presents a Compelling Value Investment Case ↗
Via Chartmill
News headline image
Lantheus Says FDA Pushed Deadline For Reviewing Its Tumor Diagnostic Kit Application ↗
Via Stocktwits
News headline image
Lantheus Announces Three-Month Extension of PDUFA Date for LNTH-2501 (Ga 68 edotreotide), a PET Diagnostic Imaging Kit Targeting Somatostatin Receptor-Positive (SSTR+) Neuroendocrine Tumors (NETs)
From Lantheus Holdings, Inc.
Via GlobeNewswire
News headline image
3 Reasons to Sell LNTH and 1 Stock to Buy Instead
Via StockStory
Topics Supply Chain
News headline image
Q4 Earnings Highlights: Lantheus (NASDAQ:LNTH) Vs The Rest Of The Medical Devices & Supplies - Imaging, Diagnostics Stocks
Via StockStory
Topics Artificial Intelligence
News headline image
Why Lantheus Holdings Stock Popped by Almost 12% Last Month ↗
Via The Motley Fool
News headline image
Why Is LNTH Stock Up After Hours? ↗
Via Stocktwits
News headline image
Lantheus Announces FDA Approval of PYLARIFY TruVu™ (piflufolastat F 18) Injection
From Lantheus Holdings, Inc.
Via GlobeNewswire
News headline image
Lantheus Holdings Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Lantheus Holdings, Inc. - LNTH
From Kahn Swick & Foti, LLC
Via Business Wire
News headline image
Lantheus Receives FDA Tentative Approval for Lutetium Lu 177 Dotatate (PNT2003), Radioequivalent to LUTATHERA®
From Lantheus Holdings, Inc.
Via GlobeNewswire
News headline image
Lantheus (LNTH) Q4 2025 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings
News headline image
Lantheus (NASDAQ:LNTH) Exceeds Q4 CY2025 Expectations
Via StockStory
News headline image
Lantheus Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
From Lantheus Holdings, Inc.
Via GlobeNewswire
News headline image
Lantheus Earnings: What To Look For From LNTH
Via StockStory
Topics Economy World Trade
News headline image
Lantheus to Present at March 2026 Investor Conferences
From Lantheus Holdings, Inc.
Via GlobeNewswire
News headline image
2 Value Stocks to Target This Week and 1 Facing Headwinds
Via StockStory
News headline image
Lantheus to Host Fourth Quarter and Full Year 2025 Earnings Conference Call and Webcast on February 26, 2026, at 8:00 a.m. Eastern Time
From Lantheus Holdings, Inc.
Via GlobeNewswire
News headline image
2 Small-Cap Stocks Worth Investigating and 1 We Avoid
Via StockStory
News headline image
Lantheus Holdings Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Lantheus Holdings, Inc. - LNTH
From Kahn Swick & Foti, LLC
Via Business Wire
News headline image
3 Market-Beating Stocks for Long-Term Investors
Via StockStory

Frequently Asked Questions

Is Lantheus Holdings, Inc. - Common Stock publicly traded?
Yes, Lantheus Holdings, Inc. - Common Stock is publicly traded.
What exchange does Lantheus Holdings, Inc. - Common Stock trade on?
Lantheus Holdings, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Lantheus Holdings, Inc. - Common Stock?
The ticker symbol for Lantheus Holdings, Inc. - Common Stock is LNTH on the Nasdaq Stock Market
What is the current price of Lantheus Holdings, Inc. - Common Stock?
The current price of Lantheus Holdings, Inc. - Common Stock is 83.94
When was Lantheus Holdings, Inc. - Common Stock last traded?
The last trade of Lantheus Holdings, Inc. - Common Stock was at 04/15/26 04:00 PM ET
What is the market capitalization of Lantheus Holdings, Inc. - Common Stock?
The market capitalization of Lantheus Holdings, Inc. - Common Stock is 5.67B
How many shares of Lantheus Holdings, Inc. - Common Stock are outstanding?
Lantheus Holdings, Inc. - Common Stock has 6B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story